文献

J-GLOBAL ID：201902273981001641   整理番号：19A2078695

腫瘍長軸直径とSUVmaxは90Y-イブリツモマブチウキセタン単独療法における長期応答者を予測する

Tumor long-axis diameter and SUVmax predict long-term responders in 90Y-ibritumomab tiuxetan monotherapy

著者 (19件)： Tsukamoto Norifumi (Oncology Center, Gunma University Hospital, Maebashi, Gunma, Japan) ,  Tsukamoto Norifumi (Department of Hematology, Gunma University Graduate School of Medicine, Maebashi, Japan) ,  Yokohama Akihiko (Department of Hematology, Gunma University Graduate School of Medicine, Maebashi, Japan) ,  Yokohama Akihiko (Transfusion Service, Gunma University Hospital, Maebashi, Japan) ,  Higuchi Tetsuya (Department of Diagnostic Radiology and Nuclear Medicine, University Graduate School of Medicine, Maebashi, Japan) ,  Mitsui Takeki (Department of Hematology, Gunma University Graduate School of Medicine, Maebashi, Japan) ,  Koiso Hiromi (Department of Hematology, Gunma University Graduate School of Medicine, Maebashi, Japan) ,  Takizawa Makiko (Department of Hematology, Gunma University Graduate School of Medicine, Maebashi, Japan) ,  Shimizu Hiroaki (Department of Hematology, Gunma University Graduate School of Medicine, Maebashi, Japan) ,  Ishizaki Takuma (Department of Hematology, Gunma University Graduate School of Medicine, Maebashi, Japan) ,  Matsumoto Morio (Department of Hematology, National Hospital Organization Shibukawa Medical Center, Shibukawa, Japan) ,  Toyama Kohtaro (Division of Internal Medicine, Fujioka General Hospital, Fujioka, Japan) ,  Sakura Tohru (Division of Internal Medicine, Saiseikai Maebashi Hospital, Maebashi, Japan) ,  Ogura Hidemi (Division of Internal Medicine, Maebashi Red Cross Hospital, Maebashi, Japan) ,  Saitoh Takayuki (Department of Laboratory Sciences, Gunma University Graduate School of Health Sciences, Maebashi, Japan) ,  Ishida Fumihiro (Department of Biomedical Laboratory Medicine, Shinshu University School of Medicine, Matsumoto, Nagano, Japan) ,  Murakami Hirokazu (Department of Laboratory Sciences, Gunma University Graduate School of Health Sciences, Maebashi, Japan) ,  Tsushima Yoshito (Department of Diagnostic Radiology and Nuclear Medicine, University Graduate School of Medicine, Maebashi, Japan) ,  Handa Hiroshi (Department of Hematology, Gunma University Graduate School of Medicine, Maebashi, Japan)
資料名： International Journal of Hematology  (International Journal of Hematology)
巻： 109  号： 1  ページ： 91-97  発行年： 2019年01月 
JST資料番号： F0888A  ISSN： 0925-5710  CODEN： IJHEEY  資料種別： 逐次刊行物 (A)
記事区分： 原著論文  発行国： ドイツ (DEU)  言語： 英語 (EN)

抄録/ポイント： 90Y-イブリツモマブチウキセタン(90Y-IT)は広く使用...

シソーラス用語： ヒト ,...
準シソーラス用語： *90Y標識抗CD20抗体 ,...

ログイン（無料）して見る     続きはJDreamIII（有料）にて  {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=19A2078695&from=J-GLOBAL&jstjournalNo=F0888A") }}

著者キーワード (4件)： 悪性リンパ腫 ,  90Y-Ibrituomab Tiuxetan ,  腫瘍直径 ,  FDG-PET

分類 (4件)： 血液の腫よう  (GK04000M) ,  腫ようの薬物療法  (GE03032C) ,  抗腫よう薬の臨床への応用  (GW16020L) ,  放射性医薬品の臨床への応用  (GW18020Z)

タイトルに関連する用語 (8件)： 腫瘍 ,  直径 ,  SUVmax ,  イブリツモマブチウキセタン ,  単独療法 ,  長期 ,  応答 ,  予測